Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Health products for reducing fat

A technology for health products and lipid-lowering, which is applied in the field of health products and can solve problems such as kidney damage, drug side effects, and weight rebound

Active Publication Date: 2008-12-17
HARBIN MEDICAL UNIVERSITY
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to solve the problems of gastrointestinal dysfunction, anemia, diabetes, renal function damage, weight rebound and drug side effects when consumers take the existing weight-loss health products or lipid-lowering health products, the present invention provides a weight-loss diet Lipid-lowering health products

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Health products for reducing fat
  • Health products for reducing fat
  • Health products for reducing fat

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0009] Specific embodiment 1: The slimming and lipid-lowering health product of this embodiment is composed of tablet A and tablet B at a ratio of 1:1; wherein tablet A is composed of 10.0% to 20.0% chitosan, 25.0% %~35.0% of L-carnitine, 0.01%~0.06% of chromium picolinate, 25.0%~35.0% of calcium pyruvate and the rest of auxiliary materials; Tablet B consists of 4.0%~8.0% of mixed vitamins by weight , 30.0% to 40.0% of mixed minerals, 30.0% to 40.0% of linolenic acid and the balance of auxiliary materials.

[0010] The chitosan added in the tablet A of this embodiment is a polymer substance with a positive charge, while the excess fat in the human body is negatively charged, so weight loss and lipid-lowering drugs absorb excess fat in the body by adding chitosan. Fat is then excreted from the body through metabolism.

[0011] The addition of L-carnitine in Tablet A of this embodiment is mainly used as a carrier to transport long-chain fatty acids from the outside of the mitoc...

specific Embodiment approach 2

[0016] Specific embodiment two: the difference between this embodiment and specific embodiment one is: Tablet A consists of 12.0%~18.0% chitosan, 28.0%~32.0% L-carnitine, 0.02%~0.04% by weight % of chromium picolinate, 28.0% to 32.0% of calcium pyruvate and the balance of auxiliary materials. Others are the same as in the first embodiment.

specific Embodiment approach 3

[0017] Specific embodiment three: the difference between this embodiment and specific embodiment one is: Tablet A consists of 15.0% chitosan, 30.0% L-carnitine, 0.03% chromium picolinate, 30.0% Calcium pyruvate and the remainder of auxiliary materials. Others are the same as in the first embodiment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A weight-losing and lipid-lowering health care product relates to a health care product. The weight-losing and lipid-lowering health care product can solve the problems of gastrointestinal functional disorders, anemia, diabetes, renal dysfunction, weight rebound phenomenon and toxic and side effects of drugs when in administration of the existing weight-losing health care products or the lipid-lowering health care products by a person. The weight-losing and lipid-lowering health care product is composed of a tablet A and a table B; wherein, the tablet A is composed of chitosan, L-carnitine, chromium picolinate, calcium pyruvate and excipients; and the tablet B is composed of mixed vitamins, mixed minerals, linolenic acid and the excipients. The weight-losing and lipid-lowering drug of the invention can reduce the body weight for 3.17 plus or minus 1.56Kg after 45 days, lower the body fat for 2.83 plus or minus 1.19Kg and significantly reduce the subcutaneous fat of other parts; the average decrease rate of cholesterol is 10.48 plus or minus 5.11 percent, the average decrease rate of triglyceride is 19.57 plus or minus 8.12 percent, the total effective rate is 52.94 percent, the effects of weight-losing and lipid-lowering are significant, the weight-losing and lipid-lowering drug has no toxicity or side effects and no weight rebound.

Description

technical field [0001] The invention relates to a health product. Background technique [0002] With the continuous improvement of human living standards and changes in people's diet structure, the proportion of obese and hyperlipidemia in the population continues to increase. Obesity and excessive blood lipids are the main causes of cardiovascular and cerebrovascular diseases, diabetes, arteriosclerosis and other diseases. Cardiovascular and cerebrovascular diseases kill 12 million people every year worldwide, which is close to 1 / 4 of the total global death population. Great social harm, the death population of cardiovascular and cerebrovascular accounts for the first place of total death population in our country, this phenomenon obviously seriously threatens the life and health of mankind. [0003] At present, although there are many kinds of health care products and medicines for weight loss and fat reduction in the market, because weight loss products mainly achieve th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23L1/29A23L1/30A23L1/302A23L1/304A23L1/303A23L33/12A23L33/125A23L33/15A23L33/16A23L33/175
Inventor 孙长颢李颖王骋闻颖刘丽康真牛玉存
Owner HARBIN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com